The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 25, 2021

Filed:

Jan. 10, 2020
Applicant:

Foresee Pharmaceuticals Co., Ltd., Taipei, TW;

Inventors:

Yuhua Li, Landenberg, PA (US);

ChiaTing Huang, New Taipei, TW;

John Mao, San Bruno, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/40 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 31/4178 (2006.01); A61K 9/48 (2006.01); A61K 9/16 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 47/40 (2013.01); A61K 9/0053 (2013.01); A61K 9/10 (2013.01); A61K 9/1652 (2013.01); A61K 9/48 (2013.01); A61K 31/4178 (2013.01); A61K 47/183 (2013.01);
Abstract

The present invention provides compositions or formulations comprising the combination of a compound of 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione or a salt thereof or hydrate of the foregoing, and a cyclodextrin; or in further combination with an excipient comprising L-Arginine or other additives, wherein the compositions or formulations increases water solubility and oral bioavailability of 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione and its related compounds. The method of making or using the compositions or formulations is also disclosed. Such compositions or formulations may be used in treatment of certain diseases including asthma through inhibition of matrix metalloproteinase-12.


Find Patent Forward Citations

Loading…